DrugPatentWatch Database Preview
MORPHABOND ER Drug Profile
» See Plans and Pricing
When do Morphabond Er patents expire, and what generic alternatives are available?
Morphabond Er is a drug marketed by Daiichi Sankyo Inc and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.
This drug has twenty-three patent family members in ten countries.
The generic ingredient in MORPHABOND ER is morphine sulfate. There are twenty-three drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Morphabond Er
A generic version of MORPHABOND ER was approved as morphine sulfate by HOSPIRA on May 11th, 1988.
Summary for MORPHABOND ER
International Patents: | 23 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Bulk Api Vendors: | 23 |
Patent Applications: | 3,147 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for MORPHABOND ER |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for MORPHABOND ER |
DailyMed Link: | MORPHABOND ER at DailyMed |


Paragraph IV (Patent) Challenges for MORPHABOND ER
Tradename | Dosage | Ingredient | NDA | Submissiondate |
---|---|---|---|---|
MORPHABOND ER | TABLET, EXTENDED RELEASE;ORAL | morphine sulfate | 206544 | 2019-01-28 |
US Patents and Regulatory Information for MORPHABOND ER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Daiichi Sankyo Inc | MORPHABOND ER | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 206544-001 | Oct 2, 2015 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
Daiichi Sankyo Inc | MORPHABOND ER | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 206544-004 | Oct 2, 2015 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
Daiichi Sankyo Inc | MORPHABOND ER | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 206544-002 | Oct 2, 2015 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
Daiichi Sankyo Inc | MORPHABOND ER | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 206544-004 | Oct 2, 2015 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for MORPHABOND ER
Country | Patent Number | Estimated Expiration |
---|---|---|
Brazil | PI0815387 | Start Trial |
European Patent Office | 2331080 | Start Trial |
China | 105534936 | Start Trial |
Canada | 2734075 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |